Institution statistics

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI - Italy 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:800-900
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:67
Partner Constancy:58
Project Leadership Index:64
Diversity Index:40
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding:100-200
Total Project Funding per Partner:300-400
Total Number of Projects:60
Networking Rank (Reputation):200-300
Networking Rank (Reputation):200-300
Partner Constancy:32
Project Leadership Index:60
Diversity Index:60
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):600-700
Partner Constancy:800-900
Project Leadership Index:100-200
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:700-800
Networking Rank (Reputation):900-1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:400-500
Networking Rank (Reputation):700-800
Partner Constancy:800-900
Project Leadership Index:300-400
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:200-300
Total Project Funding:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:200-300
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:100-200
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):200-300
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:100-200
Ranking timeline:

European project participation (2000-01-01 - 2017-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 63
As coordinator: 8
As participant: 54
Sole participant: 1
Coordinator / Participant Ratio: 0.15*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 32.368.464 1.975.512 4
2016 168.277 27.798.299 881.054 1 1
2015 0 41.107.898 2.889.952 6
2014 0 6.799.997 272.000 1
2013 5.443.350 31.648.498 2.965.863 1 6
2012 992.666 56.348.255 3.022.043 2 9
2011 3.564.956 16.987.353 3.807.074 2 4
2010 0 16.889.532 1.789.869 3
2009 910.929 6.648.566 851.539 1 4
2008 3.759.499 24.881.850 1.809.639 1 4
2007 112.840 22.129.259 1.218.970 1 3
2006 0 4.169.736 291.588 2
2005 0 21.185.678 1.094.215 2
2004 0 12.780.339 747.110 4
2003 0 15.550.000 518.333 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE18
KAROLINSKA INSTITUTE11
ACADEMISCH ZIEKENHUIS GRONINGEN8
CHARITE UNIVERSITAETSMEDIZIN BERLIN7
MEDIZINISCHE UNIVERSITAET WIEN7
UNIVERSITAET ULM6
UNIVERSITAET ZUERICH6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
HEINRICHHEINEUNIVERSITAET DUESSELDORF5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
INSERM TRANSFERT5
ISTITUTO SUPERIORE DI SANITA5
KING'S COLLEGE LONDON5
MEDIZINISCHE UNIVERSITAT INNSBRUCK5
MOSAIQUES DIAGNOSTICS5
REGION HOVEDSTADEN5
UNIVERSITA DEGLI STUDI DI FIRENZE5
UNIVERSITY COLLEGE LONDON5
UNIVERSITY OF GLASGOW5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
CONSORZIO ITALIANO PER LA RICERCA IN MEDICINA4
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA4
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O4
LUNDS UNIVERSITET4
MEDICAL RESEARCH COUNCIL4
MOLECULAR MEDICINE IRELAND LBG4
SEMMELWEIS EGYETEM4
THE UNIVERSITY OF MANCHESTER4
THE UNIVERSITY OF NOTTINGHAM4
UNIVERSITAETSKLINIKUM AACHEN4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
UNIVERSITY OF LEEDS4
ARTTIC3
DANMARKS TEKNISKE UNIVERSITET3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
DOUGLAS CONNECT3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
HUMANITAS MIRASOLE3
ITAE SUOMEN YLIOPISTO3
KATHOLIEKE UNIVERSITEIT LEUVEN3
KLINIKUM DER UNIVERSITAET ZU KOELN3
LEIDEN UNIVERSITY MEDICAL CENTER3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MEDIZINISCHE HOCHSCHULE HANNOVER3
POLITECNICO DI MILANO3
TECHNISCHE UNIVERSITAET DRESDEN3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN3
THE UNIVERSITY OF LIVERPOOL3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITATSKLINIKUM ERLANGEN3
UNIVERSITE D'AIX MARSEILLE3
UNIVERSITEIT ANTWERPEN3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF BRISTOL3
UNIVERSITY OF HELSINKI3
WARSZAWSKI UNIWERSYTET MEDYCZNY3
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS LEIDEN2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
AMGEN2
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII2
BENGURION UNIVERSITY OF THE NEGEV2
BIOTALENTUM TUDASFEJLESZTO KFT2
CENTRE HOSPITALIER CHRETIEN ASBL2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CENTRO DE INVESTIGACION BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS2
CF CONSULTING FINANZIAMENTI UNIONE EUROPEA2
CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EGESZSEGUGY MINISZTERIUMI2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FERRER INTERNATIONAL2
FILARETE SERVIZI2
FINNMEDI OY2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III2
GOETEBORGS UNIVERSITET2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HACETTEPE UNIVERSITESI2
HEALTH PROTECTION AGENCY2
INSTITUT CATALA D'ONCOLOGIA2
INSTITUT CATALA DE LA SALUT2
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE2
INSTITUTE FOR RESEARCH IN BIOMEDICINE2
INSTITUTO DE SALUD CARLOS III2
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI2
KAROLINSKA UNIVERSITY HOSPITAL2
KLINIKUM DER UNIVERSITAET REGENSBURG2
LIVERPOOL JOHN MOORES UNIVERSITY2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
Constancy:

Total number of partners:880

Partner loyalty:
Frequent Partner: (> 2 projects): 265
Rare Partner: 615

Frequent / Rare Partner Ratio: 0.43

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES35
RTD HORIZONTAL TOPICS19
SOCIAL AND ECONOMIC CONCERNS8
INDUSTRY AND TECHNOLOGY2
PROTECTING MAN AND HIS ENVIRON2
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2017-04-01European School for Interdisciplinary Tinnitus Research ESITparticipant3.823.89712
2017-01-06Biomarker Enterprise to Attack DKD BEAt-DKDparticipant15.085.93722
2017-01-01European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment ESCAPE-NETparticipant9.992.88116
2017-01-01Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease BBDiagparticipant3.465.75010
2016-09-01Chronic kidney disease and acute kidney injury – evaluation of EU and global epidemiology CKD AKIcoordinator168.2771
2016-01-01An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century EU-ToxRiskparticipant27.798.29939
2015-11-01Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. TackSHSparticipant2.987.79411
2015-10-05Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications PEPTICAPSparticipant3.852.2949
2015-09-01a LOW environmental impact BRAke SYStem LOWBRASYSparticipant7.436.85011
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80035
2015-05-01Novel Stromal Cell Therapy for Diabetic Kidney Disease NEPHSTROMparticipant5.994.37411
2015-05-01Secondary prEvention of CardiovascUlaR disease in the Elderly trial SECUREparticipant5.998.78611
2014-01-01Framework to respond to regulatory needs of future nanomaterials and markets FUTURENANONEEDSparticipant6.799.99725
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2013-10-01MULTISCALE APPROACH TO THE IDENTIFICATION OF MOLECULAR BIOMARKERS IN ACUTE HEART FAILURE INDUCED BY SHOCK SHOCKOMICSparticipant5.174.00111
2013-10-01Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe CREACTIVEcoordinator5.443.3509
2013-08-01A Gateway to European Kidney Research Resources - KidneyConnect KIDNEYCONNECTparticipant499.97817
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-01-01"Modelling properties, interactions, toxicity and environmental behaviour of engineered nanoparticles" NANOPUZZLESparticipant976.8105
2013-01-01Predictive toxicology of engineered nanoparticles PRENANOTOXparticipant997.7343
2012-12-01Translational research (training) in Polycystic Kidney Disease TRANCYSTparticipant2.763.7337
2012-11-01Stem-cell based therapy for kidney repair STELLARparticipant5.998.05013
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-10-01A new paradigm in drug use and human health risk assessment: Sewage profiling at the community level SEWPROFparticipant4.178.23111
2012-09-01European Communication on Research Awareness Needs ECRANcoordinator892.6669
2012-06-01Search for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancer muscleandcancercoordinator100.0002
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01European Clinical Research Infrastructures Network - Integrating Activity ECRIN-IAparticipant7.999.93147
2012-01-01A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease NILVADparticipant5.999.97817
2012-01-01Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria PRIORITYparticipant5.980.50020
2012-01-01Building bridges between specialists on computational and empirical risk assessment of engineered nanomaterials NanoBRIDGESparticipant491.6005
2011-11-01Overcome failure to Publish nEgative fiNdings OPENparticipant499.99111
2011-05-01Dreaming of no more renal dialysis: how self-derived tissue and cells can replace renal function RESETparticipant2.493.0001
2011-02-01European multidisciplinary ALS network identification to cure motor neuron degeneration Euro-MOTORparticipant8.994.36215
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2participant5.000.00016
2011-01-01ToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology TOXBANKcoordinator1.564.99610
2011-01-01Coordinating resources to assess and improve health status of migrants from Latin America COHEMIcoordinator1.999.96010
2010-08-01THE HYGIENE HYPOTHESIS : REVISITING THE CONCEPT BY INTEGRATING EPIDEMIOLOGY AND MECHANISTIC STUDIES HYGIENEparticipant2.099.9992
2010-07-01Fixed Dose Combination drugs for Secondary Cardiovascular Prevention FOCUSparticipant2.999.9999
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429
2009-09-01Risk-based management of chemicals and products in a circular economy at a global scale RISKCYCLEparticipant996.14818
2009-09-01Organising dissemination on results of projects on chemical evaluation, spreading techniques for risk assessment ORCHESTRAcoordinator910.9297
2009-07-01European Network of Bipolar Research Expert Centres ENBRECparticipant662.9006
2009-02-01Pricing policies and control of tobacco in Europe PPACTEparticipant2.991.6568
2009-02-01European paediatric oncology off-patent medicines consortium EPOCparticipant1.997.86211
2008-11-01Set up and comparison of multiple stem cell approaches for kidney repair STAR-T REKparticipant2.999.50011
2008-11-01Evaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonates TINNparticipant5.161.00016
2008-09-01Nanoparticles for therapy and diagnosis of Alzheimer disease NADparticipant10.921.35019
2008-06-01Patient specific image-based computational modelling for \nimprovement of short- and long-term outcome of vascular access \nin patient on hemodialysis therapy ARCHcoordinator3.759.49910
2008-03-01European clinical research infrastructures network for clinical trials and biotherapy - preparatory phase for the infrastructure ECRIN-PPIparticipant5.800.00022

overview shows latest 50 from 63 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here:

Alias institution names:
  • ISTITUTO DI RECERCHE FARMACOLOGICHE "MARIO NEGRI"
  • ISTITUTO DI RICERCHE FARMACOLOGICHE
  • ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
  • ISTITUTO DI RICHERCHE FARMACOLOGICHE "MARIO NEGRI"

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: